First Personal Financial Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $116 | Buy |
+1
| New | +$116 | ﹤0.01% | 527 |
|
|
2023
Q4 | – | Sell |
-28
| Closed | -$3.15K | – | 393 |
|
|
2023
Q3 | $3.15K | Hold |
28
| – | – | ﹤0.01% | 354 |
|
|
2023
Q2 | $2.64K | Hold |
28
| – | – | ﹤0.01% | 356 |
|
|
2023
Q1 | $2.84K | Hold |
28
| – | – | ﹤0.01% | 377 |
|
|
2022
Q4 | $3.34K | Hold |
28
| – | – | ﹤0.01% | 363 |
|
|
2022
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 402 |
|
|
2022
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 316 |
|
|
2022
Q1 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 321 |
|
|
2018
Q2 | – | Sell |
-606
| Closed | -$50K | – | 844 |
|
|
2018
Q1 | $50K | Sell |
606
-152
| -20% | -$12.5K | 0.01% | 435 |
|
|
2017
Q4 | $59K | Buy |
758
+68
| +10% | +$5.29K | 0.01% | 439 |
|
|
2017
Q3 | $42K | Hold |
690
| – | – | 0.01% | 461 |
|
|
2017
Q2 | $32K | Buy |
690
+150
| +28% | +$6.96K | 0.01% | 501 |
|
|
2017
Q1 | $23K | Buy |
540
+127
| +31% | +$5.41K | 0.01% | 539 |
|
|
2016
Q4 | $16K | Buy |
+413
| New | +$16K | ﹤0.01% | 594 |
|
|
2016
Q3 | – | Sell |
-19
| Closed | -$1K | – | 833 |
|
|
2016
Q2 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 794 |
|